Rockefeller Capital Management L.P. - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q4 2022$03580.0%0.00%
Q3 2022$03580.0%0.00%
Q2 2022$03580.0%0.00%
Q1 2022$03580.0%0.00%
Q4 2021$03580.0%0.00%
Q3 2021$0
-100.0%
3580.0%0.00%
Q2 2021$1,0000.0%3580.0%0.00%
Q1 2021$1,0000.0%3580.0%0.00%
Q4 2020$1,0003580.0%0.00%
Q3 2020$0
-100.0%
3580.0%0.00%
Q2 2020$1,0003580.0%0.00%
Q1 2020$0
-100.0%
3580.0%0.00%
Q4 2019$1,0000.0%3580.0%0.00%
Q3 2019$1,0003580.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Tejara Capital Ltd 3,215,001$4,147,3512.35%
Soleus Capital Management, L.P. 9,677,419$12,483,8711.15%
683 Capital Management, LLC 6,000,000$7,740,0000.60%
Rubric Capital Management LP 11,616,120$14,984,7950.56%
MANGROVE PARTNERS IM, LLC 5,531,547$7,135,6960.54%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,364,438$9,500,1250.51%
DAFNA Capital Management LLC 962,513$1,241,6420.39%
Clearline Capital LP 3,102,723$4,002,5120.34%
Rock Springs Capital Management LP 7,676,481$9,902,6600.26%
Monaco Asset Management SAM 595,729$768,4900.23%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders